262 results on '"Alison Reid"'
Search Results
2. Data from Interventions to Reduce Future Cancer Incidence from Diesel Engine Exhaust: What Might Work?
- Author
-
Alison Reid, Geza Benke, Deborah C. Glass, Susan Peters, Timothy R. Driscoll, Lin Fritschi, and Renee N. Carey
- Abstract
Exposure to diesel engine exhaust (DEE) contributes appreciably to the burden of occupational cancer. This study aims to estimate the potential impact of a range of interventions on the future burden of cancer from occupational exposure to DEE in Australia. The future excess fraction method, a novel method based on the lifetime risk approach, was used to model changes in the future burden of cancer among the Australian working age population exposed to DEE at work in 2012 under various intervention strategies. The interventions modeled were based on the widely accepted hierarchy of control model. At baseline, 600 (0.4%) future bladder and 4,450 (0.6%) future lung cancer cases over the lifetime of the cohort were estimated to be attributable to occupational exposure to DEE in those exposed in 2012. Up to 2,000 of these cases were estimated to be avoidable through the use of various interventions. Exhaust hoses (engineering controls) were estimated to be particularly effective. This study provides an indication of which intervention strategies may be most useful in reducing the future burden of cancer associated with occupational DEE exposure. These results show the potential effect of changing current exposure, rather than focusing on past exposures, and thus provide relevant information for policy planning.
- Published
- 2023
- Full Text
- View/download PDF
3. Table S1 from Interventions to Reduce Future Cancer Incidence from Diesel Engine Exhaust: What Might Work?
- Author
-
Alison Reid, Geza Benke, Deborah C. Glass, Susan Peters, Timothy R. Driscoll, Lin Fritschi, and Renee N. Carey
- Abstract
Sensitivity Analysis - Bladder
- Published
- 2023
- Full Text
- View/download PDF
4. Geographic distribution of malignant mesothelioma incidence and survival in Australia
- Author
-
Jessica K. Cameron, Joanne Aitken, Alison Reid, Kerrie Mengersen, Susanna Cramb, Paige Preston, Bruce Armstrong, and Peter Baade
- Subjects
Mesothelioma ,Pulmonary and Respiratory Medicine ,Cancer Research ,Lung Neoplasms ,Oncology ,Incidence ,Occupational Exposure ,Mesothelioma, Malignant ,Australia ,Humans ,Asbestos ,Bayes Theorem - Abstract
To understand the geographic distribution of and area-level factors associated with malignant mesothelioma incidence and survival in Australia.Generalised linear models and Bayesian spatial models were fitted using population registry data. Area-level covariates were socioeconomic quintile, remoteness category and state or territory. The maximised excess events test was used to test for spatial heterogeneity.There was strong evidence of spatial differences in standardised incidence rates for malignant mesothelioma but survival was uniformly poor. Incidence rates varied by state or territory and were lower in remote areas. Patterns in the geographic distribution of modelled incidence counts for malignant mesothelioma differed substantially from patterns of standardised incidence rates.Geographic variation in the modelled incidence counts of malignant mesothelioma demonstrates varying demand for diagnostic and management services. The long latency period for this cancer coupled with migration complicates any associations with patterns of exposure, however some of the geographic distribution of diagnoses can be explained by the location of historical mines and asbestos-related industries.
- Published
- 2022
- Full Text
- View/download PDF
5. Determinants of violence towards care workers working in the home setting: A systematic review
- Author
-
Nang Nge Nge Phoo and Alison Reid
- Subjects
Mental Health ,Health Personnel ,Public Health, Environmental and Occupational Health ,Home Health Aides ,Humans ,Violence ,Home Care Services - Abstract
Home care is a rapidly growing industry. Violence towards home care workers is common, while also likely underreported. This violence adversely affects the physical and mental health of both workers and care recipients. The current study aims to identify and appraise recent evidence on the determinants of violence towards care workers working in the home setting.Six electronic databases: the Cumulative Index to Nursing and Allied Health Literature (CINAHL), EMBASE, Informit, Medline, PsycINFO, and Web of Science, were systematically searched. A systematic review was conducted in accordance with the Joanna Briggs Institute manual for evidence synthesis.A total of 18 papers met the inclusion criteria. All were cross-sectional surveys. The majority of studies were from the United States. The most commonly investigated associations were those between the medical history of clients, workers' apprehension of violence, worker-client relationship, or care plans, and any form of violence or verbal abuse.Violence was common in clients with cognitive disorders, substance abuse disorder, and limited mobility; toward workers who feared that violence might happen; toward those who had very close or very distant worker-client relationships; and when care plans were not inclusive of clients' needs. The current review highlights a gap in evidence on determinants of violence towards care workers working in the home setting, and suggests potential areas to be addressed to reduce such violence.
- Published
- 2022
- Full Text
- View/download PDF
6. Data from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Author
-
Jaap Verweij, Johann S. deBono, Paul Workman, Ferry Eskens, Stan B. Kaye, Ian R. Judson, Begona de las Heras, Luis López Lázaro, Lyndsey Welsh, Alison Reid, Sarah Reade, Andre Planting, Paul A. Clarke, Jos Kitzen, and Richard D. Baird
- Abstract
A dose-escalation, phase I study evaluated the safety, pharmacokinetics, pharmacogenomics, and efficacy of ES-285, a novel agent isolated from a marine mollusc, in adult cancer patients. Patients received a 24-hour i.v. infusion of ES-285 once every 3 weeks until disease progression or unacceptable toxicity. The starting dose was 4 mg/m2. Dose escalation in cohorts of at least three patients proceeded according to the worst toxicity observed in the previous cohort. Twenty-eight patients were treated with 72 courses of ES-285 across eight dose levels. No dose-limiting toxicities were seen between 4 and 128 mg/m2. Two of four patients treated at 256 mg/m2 had dose-limiting reversible grade 3 transaminitis; one patient at 256 mg/m2 also had transient grade 3 central neurotoxicity. One of three patients subsequently treated at 200 mg/m2 died following drug-related central neurotoxicity. Other toxicities included phlebitis, nausea, fatigue, and fever. Pharmacokinetic studies indicated dose proportionality with high volume of distribution (median Vss at 256 mg/m2 was 2,389 liters; range, 1,615–4,051 liters) and long elimination half life (median t1/2 at 256 mg/m2 was 28 h; range, 21–32 h). The three patients with dose-limiting toxicity had the highest drug exposure. Pharmacogenomic studies of paired surrogate tissue samples identified changes in gene expression following treatment that correlated with increasing dose. Disease stabilization for 6 to 18 weeks was recorded in nine patients. Using this schedule, 128 mg/m2 was considered safe and feasible. At this dose, pharmacologically relevant concentrations of the drug were safely achieved with pharmacogenomic studies indicating changes in the expression of genes of potential mechanistic relevance. [Mol Cancer Ther 2009;8(6):1430–7]
- Published
- 2023
- Full Text
- View/download PDF
7. Supplementary Table S3 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Author
-
Jaap Verweij, Johann S. deBono, Paul Workman, Ferry Eskens, Stan B. Kaye, Ian R. Judson, Begona de las Heras, Luis López Lázaro, Lyndsey Welsh, Alison Reid, Sarah Reade, Andre Planting, Paul A. Clarke, Jos Kitzen, and Richard D. Baird
- Abstract
Supplementary Table S3 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Published
- 2023
- Full Text
- View/download PDF
8. Supplementary Fig. S1 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Author
-
Jaap Verweij, Johann S. deBono, Paul Workman, Ferry Eskens, Stan B. Kaye, Ian R. Judson, Begona de las Heras, Luis López Lázaro, Lyndsey Welsh, Alison Reid, Sarah Reade, Andre Planting, Paul A. Clarke, Jos Kitzen, and Richard D. Baird
- Abstract
Supplementary Fig. S1 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Published
- 2023
- Full Text
- View/download PDF
9. Supplementary Fig. S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Author
-
Jaap Verweij, Johann S. deBono, Paul Workman, Ferry Eskens, Stan B. Kaye, Ian R. Judson, Begona de las Heras, Luis López Lázaro, Lyndsey Welsh, Alison Reid, Sarah Reade, Andre Planting, Paul A. Clarke, Jos Kitzen, and Richard D. Baird
- Abstract
Supplementary Fig. S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Published
- 2023
- Full Text
- View/download PDF
10. Supplementary Table S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Author
-
Jaap Verweij, Johann S. deBono, Paul Workman, Ferry Eskens, Stan B. Kaye, Ian R. Judson, Begona de las Heras, Luis López Lázaro, Lyndsey Welsh, Alison Reid, Sarah Reade, Andre Planting, Paul A. Clarke, Jos Kitzen, and Richard D. Baird
- Abstract
Supplementary Table S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Published
- 2023
- Full Text
- View/download PDF
11. Supplementary Table S1 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Author
-
Jaap Verweij, Johann S. deBono, Paul Workman, Ferry Eskens, Stan B. Kaye, Ian R. Judson, Begona de las Heras, Luis López Lázaro, Lyndsey Welsh, Alison Reid, Sarah Reade, Andre Planting, Paul A. Clarke, Jos Kitzen, and Richard D. Baird
- Abstract
Supplementary Table S1 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- Published
- 2023
- Full Text
- View/download PDF
12. HIV-Related Knowledge and Practices among Asian and African Migrants Living in Australia: Results from a Cross-Sectional Survey and Qualitative Study
- Author
-
Daniel Vujcich, Alison Reid, Graham Brown, Jo Durham, Rebecca Guy, Lisa Hartley, Limin Mao, Amy B. Mullens, Meagan Roberts, and Roanna Lobo
- Subjects
Asia ,interviews ,Health, Toxicology and Mutagenesis ,Africa ,surveys and questionnaires ,Public Health, Environmental and Occupational Health ,sexual health ,Australia ,HIV ,focus group discussions ,migrants ,ethnic groups - Abstract
Australian HIV notification rates are higher for people born in Northeast Asia, Southeast Asia and sub-Saharan Africa compared to Australian-born people. The Migrant Blood-Borne Virus and Sexual Health Survey represents the first attempt to build the national evidence base regarding HIV knowledge, risk behaviors and testing among migrants in Australia. To inform survey development, preliminary qualitative research was conducted with a convenience sample of n = 23 migrants. A survey was developed with reference to the qualitative data and existing survey instruments. Non-probability sampling of adults born in Northeast Asia, Southeast Asia and sub-Saharan Africa was undertaken (n = 1489), and descriptive and bivariate analyses of data were conducted. Knowledge of pre-exposure prophylaxis was low (15.59%), and condom use at last sexual encounter was reported by 56.63% of respondents engaging in casual sex, and 51.80% of respondents reported multiple sexual partners. Less than one-third (31.33%) of respondents reported testing for any sexually transmitted infection or blood-borne virus in the previous two years and, of these, less than half (45.95%) tested for HIV. Confusion surrounding HIV testing practices was reported. These findings identify policy interventions and service improvements critically needed to reduce widening disparities regarding HIV in Australia.
- Published
- 2023
- Full Text
- View/download PDF
13. Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set
- Author
-
David Manson-Bahr, Alison Reid, Adam Pearce, Erik Mayer, Robert Huddart, and David Nicol
- Subjects
Centralisation ,medicine.medical_specialty ,Blood transfusion ,Urology ,medicine.medical_treatment ,Retroperitoneal Lymph Node ,Postchemotherapy ,Outcomes ,Retroperitoneal lymph node dissection ,Testis cancer ,medicine ,Lymph node ,National data ,RC254-282 ,business.industry ,Medical record ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Germ cell tumours ,medicine.disease ,Nephrectomy ,Diseases of the genitourinary system. Urology ,Surgery ,medicine.anatomical_structure ,Teratoma ,RC870-923 ,business - Abstract
Background Retroperitoneal lymph node dissection (RPLND) is essential for the treatment of metastatic germ cell tumours of the testis. Recommendations on the referral and management of complex urological cancers in the UK includes centralisation of services to regional centres. Objective To review contemporary PC-RPLND outcomes at a high-volume centre with a complex case-mix, and compare with national registry data. Design, setting, and participants We retrospectively reviewed the medical records of PC-RPLNDs performed for germ cell tumours at our centre between July 2012 and September 2018. Outcome measurements and statistical analysis Primary outcomes were Clavien 3+ complications, histology, rates of positive margin, relapse, in-field recurrences, and mortality. Secondary outcomes were blood loss, operation time, blood transfusion, adjuvant procedures, length of stay, and lymph node count. Surgical and histological outcomes of all RPLNDs for testicular cancers were compared with national RPLND registry data. For statistical difference, χ2 testing was used. Results and limitations A total of 178 procedures were performed, including 31 (17%) redo RPLNDs. Clavien 3+ complications occurred in 11 (7%). Histological findings in non-redo cases were the following: necrosis 24%, teratoma 62%, viable germ cell tumour 11%, and dedifferentiated cancers 3%. Rates of positive margin, relapse, and in-field recurrence were 11%, 17%, and 2%, respectively. Overall survival was 89% at a median of 36 mo. The median blood loss was 650 ml (350, 1250), with a transfusion rate of 8%. Nephrectomy, vascular reconstruction, and visceral resection was required in 12%, 6%, and 3% respectively. The median inpatient stay was 6 d (5, 8) and the median node count was 35 (20, 37). A comparison of all RPLNDs with national data showed no statistical difference in primary outcomes. Our blood transfusion rate was significantly lower (12% vs 21%, χ2 [1, N = 322] = 4.296, p = 0.038). Conclusions Centralisation led to high quality of RPLND in UK. Within that, our series (the largest in the UK) demonstrates no significant difference in outcomes despite higher complexity cases. Our blood transfusion rates are in fact lower than national figures. Complex RPLNDs should be performed in high-volume centres where possible. Patient summary In the UK, retroperitoneal lymph node dissections (RPLND) are centralised to specialist centres and the quality of surgery is high, with low complications and good histological outcomes. When compared to national data, we found no significant difference in the majority of outcomes from our high-volume centre despite our complex case-mix., Take Home Message This is the largest postchemotherapy retroperitoneal lymph node dissection (RPLND) series in the UK. Centralisation has led to a high standard of RPLNDs nationally, lower proportion of RPLNDs performed for necrosis only, and the evolution of high-volume centres. The benefits of high volume centres are the following: no significant difference in the majority of outcomes despite the higher proportion of complex cases and a reduced blood transfusion rate; transfusion is linked to poorer oncological outcomes in a number of malignancies.
- Published
- 2021
14. Expecting the Unexpected: How Regulators Can Prepare for Serious Events
- Author
-
Kgosietsile Letlape, Ian Leistikow, Alison Reid, Miguel Paniagua, Pascal Udekwu, and Health Care Governance (HCG)
- Subjects
SDG 3 - Good Health and Well-being - Published
- 2021
- Full Text
- View/download PDF
15. The use of pairwise comparisons and the Elo algorithm to quantitatively rate a large number of items in a single dimension
- Author
-
Jenny Routh, Sharmini Julita Paramasivam, Peter Cockcroft, Sarah Wood, John Remnant, Cornélie Westermann, Alison Reid, Patricia Pawson, Sheena Warman, Vishna Devi Nadarajah, and Kamalan Jeevaratnam
- Abstract
Quantitatively eliciting perspectives about a large number of similar entities (such as a list of competences) is a challenge for researchers in health profession education (HPE). Traditional survey methods may include using Likert items. However, a Likert item approach that generates absolute ratings of the entities may suffer from the “ceiling effect”, as ratings cluster at one end of the scale. This impacts on researchers’ ability to detect differences in ratings between the entities themselves and between respondent groups. This paper describes the use of pairwise comparison questions and a novel application of the Elo algorithm to generate relative ratings and rankings of a large number of entities on a unidimensional scale. A study assessing 91 student “preparedness characteristics” for veterinary workplace clinical training (WCT) in terms of their relative importance is presented as an example of this method in action. The Elo algorithm generates continuous data with measurement variability which, by definition, spans an entire spectrum: a normalised rating for each entity on a scale from zero to one. Since the ratings are relative to each other they are not susceptible to the ceiling effect. Additional advantages of the pairwise comparison question style are their low susceptibility to systematic bias and measurement error, they can be quicker and arguably more engaging to complete than Likert items, and they should carry a low cognitive load for respondents. Methods for evaluating the validity and reliability of this survey design are also described.Using pairwise comparison style questions and the Elo algorithm is an effective methodology to derive relative ratings (and rankings) of a large number of survey entities within HPE research.
- Published
- 2022
- Full Text
- View/download PDF
16. A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy
- Author
-
Alexey Rumyantsev, Xavier Garcia del Muro, Edmon M. Kwan, Christian D. Fankhauser, Egon Gonzalez-Billalabeitia, Anis A. Hamid, Giovanella Palmieri, Alexey Tryakin, Philippe L. Bedard, Anna Patrikidou, Eitan Amir, Robert Kitson, Jean M. Connors, Carsten Bokemeyer, Tina Cheng, Ben Tran, Daniel Y.C. Heng, Jose Manuel Ruiz-Morales, Daniel Castellano, Christopher Sweeney, Aude Flechon, Thomas Hermanns, Manuel Pedregal, Margaret Ottaviano, Alison Reid, Christoph Seidel, Margarida Brito, University of Zurich, and Connors, Jean M
- Subjects
2748 Urology ,Male ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,610 Medicine & health ,03 medical and health sciences ,0302 clinical medicine ,Testicular Neoplasms ,Internal medicine ,Humans ,Medicine ,Patient summary ,Testicular cancer ,Retrospective Studies ,Venous Thrombosis ,Chemotherapy ,business.industry ,Anticoagulants ,Venous Thromboembolism ,Number needed to harm ,Neoplasms, Germ Cell and Embryonal ,medicine.disease ,Pulmonary embolism ,10062 Urological Clinic ,030220 oncology & carcinogenesis ,Risk-benefit analysis ,Number needed to treat ,First line chemotherapy ,business - Abstract
It remains unclear which patients with metastatic germ cell tumours (mGCTs) need prophylactic anticoagulation to prevent venous thromboembolic events (VTEs).To assess the risk and onset of VTEs stratified by risk factors.This multi-institutional retrospective dataset included mGCT patients treated with first-line platinum-based chemotherapy.Patients with prophylactic anticoagulation were excluded.A regression analysis was performed to select risk factors for VTEs. The simulated number needed to treat (NNT) and the number needed to harm (NNH) with prophylactic anticoagulation were calculated based on the cumulative incidences retrieved from this study and hazard rates of recently published trials describing the efficacy of prophylactic anticoagulation to prevent VTEs and the risk of bleeding events.From 1120 patients, 121 (11%) had a VTE, which occurred prior to chemotherapy in 49 (4%) and on or after chemotherapy in 72 (6%). Six patients (1%) had a bleeding event without anticoagulation. After backward regression, the one risk factor for a VTE during or after chemotherapy was the use of a venous access device. The simulated cumulative VTE incidence from prophylactic anticoagulation for patients on or after chemotherapy would translate into an NNT of 45 (95% confidence interval [CI] 36-56) and an NNH of 186 (95% CI 87-506). Limitations are mainly related to the retrospective nature of the study.The mGCTs associated VTEs are most common before and during, but not after, chemotherapy. Avoiding venous access device and/or prophylactic anticoagulation with an acceptable risk-benefit profile may decrease VTE occurring on chemotherapy.We found that venous thromboembolic events (VTEs) occur rarely after chemotherapy. Based on experience of prophylactic anticoagulation in other cancers, we conclude that the risk of VTE in men undergoing chemotherapy for metastatic germ cell tumours can be decreased by thromboprophylaxis with a reasonable risk-benefit profile and by avoidance of venous access devices.
- Published
- 2021
- Full Text
- View/download PDF
17. Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
- Author
-
Mohammed Aldiwani, David Nicol, Alison Reid, Erik Mayer, Robert Huddart, Michael O'Callaghan, Adam Pearce, and Alexander Jay
- Subjects
medicine.medical_specialty ,Urology ,medicine.medical_treatment ,Retroperitoneal lymph node dissection ,Gastroenterology ,Testis Cancer ,Internal medicine ,medicine ,Nonseminoma ,Relapse ,RC254-282 ,Testicular cancer ,Cancer ,Proportional hazards model ,business.industry ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Induction chemotherapy ,medicine.disease ,Diseases of the genitourinary system. Urology ,Confidence interval ,Histopathology ,RC870-923 ,Teratoma ,business ,Germ cell - Abstract
Background Late relapse (LR) of nonseminomatous germ cell tumour (NSGCT) is uncommon, with limited data published. LR is defined as relapse occurring after a disease-free interval of 2 yr. Objective To review features of NSGCT LR in a UK tertiary centre. Design, setting, and participants A total of 3064 patients were referred from January 2005 to December 2017. We identified patients who experienced LR after initial pathology demonstrated NSGCT and reviewed data for their original and LR presentation and management. Outcome measurements and statistical analysis Outcomes included time to LR measured from the date of diagnosis, and overall survival. This was assessed using Cox proportional Hazards modelling, with stratification or adjustment for potential confounders. Results and limitations We identified 101 patients with LR; the median time to LR was 96 mo. Forty-three patients (42.6%) experienced relapse after 10 yr. Univariable log-rank testing revealed that the median time to LR was significantly shorter for patients who had not received induction chemotherapy (iCTx; 54 mo, 95% confidence interval [CI] 48–108) than for those who did (112 mo, 95% CI 84–186; p = 0.04). Patients who had received iCTx were less likely to have elevated tumour markers (36% vs 46%) and more likely to undergo initial surgical resection at LR compared to CTx-naïve patients. Postpubertal teratoma (PPT), yolk sac, and dedifferentiated elements predominated for patients with iCTx exposure, whereas active GCT or fibrosis predominated in postchemotherapy resections for CTx-naïve patients at LR. Forty-one men underwent postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) as part of their initial treatment for metastatic disease. Of these, 20 experienced LR in the retroperitoneum, with 18 undergoing repeat RPLND as part of their LR management. Fifteen of the repeat RPLND histopathology specimens had a PPT component. There have been 23 deaths overall; survival was worse for patients presenting with symptoms (13/36, 33%) and those receiving CTx and no surgery (10/17, 59%) at LR. Conclusions When LR of NSGCT occurs, it is frequently after an extended interval and is later among patients with prior iCTx, with PPT predominating. The high frequency of LR within the retroperitoneum following PC-RPLND reinforces the need for good-quality PC-RPLND. Patient summary We reviewed data for patients who had a late relapse of testicular cancer. We found that patients who did not receive chemotherapy as the first treatment for their initial diagnosis had a shorter time to relapse. Our results highlight the importance of long-term follow-up for testicular cancer., Take Home Message Late recurrence of nonseminomatous germ cell tumours most frequently occurs more than 10 yr after the initial diagnosis.
- Published
- 2021
- Full Text
- View/download PDF
18. PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation
- Author
-
Julia Murray, Clare Cruickshank, Thomas Bird, Philip Bell, John Braun, Dave Chuter, Miguel Reis Ferreira, Clare Griffin, Shama Hassan, Nabil Hujairi, Alan Melcher, Elizabeth Miles, Olivia Naismith, Miguel Panades, Lara Philipps, Alison Reid, Jan Rekowski, Pete Sankey, John Staffurth, Isabel Syndikus, Alison Tree, Anna Wilkins, and Emma Hall
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Abstract
PEARLS is a multi-stage randomised controlled trial for prostate cancer patients with pelvic and/or para-aortic PSMA-avid lymph node disease at presentation. The aim of the trial is to determine whether extending the radiotherapy field to cover the para-aortic lymph nodes (up to L1/L2 vertebral interspace) can improve outcomes for this patient group.
- Published
- 2022
19. Low dose CT detected interstitial lung abnormalities in a population with low asbestos exposure
- Author
-
Conor P Murray, E. Harris, Kuan P Lim, Alison Reid, Nicholas de Klerk, Fraser Brims, Peter Franklin, Yuben Moodley, Nita Sodhi-Berry, B. Adler, and Aw Bill Musk
- Subjects
Male ,medicine.medical_specialty ,Vital capacity ,Population ,Asbestosis ,medicine.disease_cause ,Asbestos ,Pulmonary function testing ,FEV1/FVC ratio ,DLCO ,Occupational Exposure ,Internal medicine ,Humans ,Medicine ,education ,Lung ,Aged ,education.field_of_study ,business.industry ,Public Health, Environmental and Occupational Health ,medicine.disease ,Cohort ,Female ,Tomography, X-Ray Computed ,business - Abstract
BACKGROUND The use of low dose CT (LDCT) chest is becoming more widespread in occupationally exposed populations. There is a knowledge gap as to heterogeneity in severity and the natural course of asbestosis after low levels of exposure. This study reports the characteristics of LDCT-detected interstitial lung abnormalities (ILA). METHODS The Asbestos Review Program offers annual LDCT, health assessments, and pulmonary function tests to an asbestos-exposed cohort. Asbestosis was defined using the Helsinki Consensus statement and the presence of ILA defined using a protocol for occupational CT reports. At least two of three pulmonary function tests: forced expiratory volume in 1 s (FEV1 ); forced vital capacity (FVC); and diffusion capacity for carbon monoxide (DLco) were required for analysis of physiological decline. RESULTS From 1513 cases, radiological ILA was present in 485 (32%). The cohort was 83.5% male with a median age of 68.3 years and a median (IQR) asbestos exposure of 0.7 (0.09-2.32) fiber/ml-year. A mixed occupation, mixed asbestos fiber cohort comprised the majority of the cohort (65.8%). Of those with ILA, 40 (8.2%) had an FVC decline of ≥10% and 30 (6.2%) had a DLco decline of ≥15% per year. Time since first exposure, increasing tobacco exposure and reported dyspnea were independently associated with the presence of ILA. CONCLUSIONS In this population with relatively low asbestos exposure, LDCT-detected ILA that fits criteria for asbestosis is common, but physiological decline is not. This mild chronic stable phenotype of asbestos-associated ILA contrasts with the traditionally accepted views that asbestosis requires high exposures.
- Published
- 2021
- Full Text
- View/download PDF
20. A Web-Based Audio Computer-Assisted Self-interview Application With Illustrated Pictures to Administer a Hepatitis B Survey Among a Myanmar-Born Community in Perth, Australia: Development and User Acceptance Study
- Author
-
Nang Nge Nge Phoo, Alison Reid, Roanna Lobo, Murray Davies, and Daniel Vujcich
- Subjects
Medicine (miscellaneous) ,Health Informatics - Abstract
Background Self-administered paper or electronic surveys can create accessibility issues for people with language barriers and limited literacy, whereas face-to-face interviews can create privacy issues and give rise to reporting biases, particularly in the context of sensitive subject matters. An audio computer-assisted self-interview (ACASI) offers an alternative mode of survey administration, and its use has been tested against other survey modes to determine whether the presence of a background narration helps overcome literacy and privacy issues. There are still gaps with the ACASI survey administration because audio narration alone does not assist respondents with limited literacy in choosing response options. To overcome literacy issues, a few studies have used illustrated pictures for a limited number of response options. Objective This study aimed to illustrate all the questions and response options in an ACASI application. This research is part of a larger study comparing different modes of survey administration (ACASI, face-to-face interviews, and self-administered paper surveys) to collect data on hepatitis B knowledge, attitudes, and practices among the Myanmar-born community in Perth, Australia. This study describes the 2-phase process of developing a web-based ACASI application using illustrated pictures. Methods The first phase was the preparation of the ACASI elements, such as questionnaire, pictures, brief descriptions of response options, and audio files. Each element was pretested on 20 participants from the target population. The second phase involved synchronizing all the elements into the web-based ACASI application and adapting the application features, in particular, autoplay audio and illustrated pictures. The preprototype survey application was tested for user acceptance on 5 participants from the target population, resulting in minor adjustments to the display and arrangement of response options. Results After a 12-month development process, the prototype ACASI application with illustrated pictures was fully functional for electronic survey administration and secure data storage and export. Conclusions Pretesting each element separately was a useful approach because it saved time to reprogram the application at a later stage. Future studies should also consider the participatory development of pictures and visual design of user interfaces. This picture-assisted ACASI survey administration mode can be further developed and used to collect sensitive information from populations that are usually marginalized because of literacy and language barriers.
- Published
- 2023
- Full Text
- View/download PDF
21. The role of group coaching in developing leadership effectiveness in a business school leadership development programme
- Author
-
Gloria Mbokota and Alison Reid
- Subjects
Strategy and Management ,Business and International Management - Published
- 2022
- Full Text
- View/download PDF
22. PD51-04 MEDIUM TO LONG TERM HEALTH-RELATED QUALITY OF LIFE AND TREATMENT-RELATED SIDE-EFFECTS IN PATIENTS TREATED WITH A SINGLE DOSE OF ADJUVANT CARBOPLATIN FOR HIGH-RISK SEMINOMA – RESULTS FROM A PILOT STUDY
- Author
-
Walter Cazzaniga, Adam Pearce, Chandran Tanabalan, Prabhakar Rajan, Netty Kinsella, Alison Reid, Robert Huddart, and David Nicol
- Subjects
Urology - Published
- 2022
- Full Text
- View/download PDF
23. Tumour evolvability metrics predict recurrence beyond 10 years in locally-advanced prostate cancer
- Author
-
Andrea Sottoriva, Javier Fernandez-Mateos, George Cresswell, Nicholas Trahearn, Katharine Webb, Christine Stuttle, Catherine Corbishley, Vasilis Starvrinides, Luis Zapata, Inma Spiteri, Timon Heide, Lewis Gallagher, Chela James, Annie Gao, Zsofia Kote-Jarai, Ahmet Acar, Lesley Truelove, Paula Proszek, Julia Murray, Alison Reid, Anna Wilkins, Michael Hubank, Rosalind Eeles, and David Dearnaley
- Abstract
Cancers evolve obeying Darwinian laws and therefore the evolutionary paradigm lays the ground for predictive oncology. However, the predictive power of evolutionary metrics in cancer has been seldom tested. There is a need for quantitative measurements in controlled clinical trials with long term follow-up information. This is particularly true in locally-advanced prostate cancer, which can recur more than a decade after diagnosis. Here we mapped genomic intra-tumour heterogeneity in 642 samples from 114 patients who took part in the prostate radiotherapy trials at The Royal Marsden Hospital, for which full clinical information and 12y median follow-up was available. We concomitantly assessed phenotypic (morphological) heterogeneity using deep learning in 1,923 histological sections from 250 IMRT patients (fully overlapping with the genetic set). We found that evolvability, measured as genetic divergence as well as morphological diversity, was a strong independent predictor of recurrence (respectively HR=72.06, 95% CI 2.97-1748.5, p=0.009 and HR=6.2, 95% CI 1.86-20.72, p=0.003). Combined, these two measurements together also identified a group of patients with half the median time to recurrence compared to the rest of the cohort (5.6 vs 11.5 years). We also found a small subset of MYC/FGFR1 amplified cases (4.4%) with particularly poor prognosis. The overall burden of chromosomal alterations correlated with higher Gleason score. We identified associations between 24 chromosomal arm copy number changes and Gleason score (e.g. -22q, +5p, +8q, +16p, +7p), and show that loss of chromosome 6p (encompassing the HLA locus) was correlated with markedly reduced immune cell infiltration. This study shows that combining genomics with AI-aided histopathology in clinical trials leads to the identification of novel clinical biomarkers.
- Published
- 2022
- Full Text
- View/download PDF
24. Migrant workers, essential work, and COVID‐19
- Author
-
Elena Rhonda-Perez, Alison Reid, Marc B. Schenker, Universidad de Alicante. Departamento de Enfermería Comunitaria, Medicina Preventiva y Salud Pública e Historia de la Ciencia, and Salud Pública
- Subjects
Social Values ,Meat packing industry ,media_common.quotation_subject ,Immigration ,Occupational Health Services ,Social value orientations ,Global Health ,Migrant workers ,Social Security ,Occupational safety and health ,Risk Factors ,Pandemic ,Humans ,Medicine ,Health Workforce ,Socioeconomics ,Occupational Health ,media_common ,Transients and Migrants ,business.industry ,Insurance Benefits ,Public Health, Environmental and Occupational Health ,COVID-19 ,Occupational Diseases ,Social security ,Cross-Sectional Studies ,Socioeconomic Factors ,Essential workers ,Work (electrical) ,Medicina Preventiva y Salud Pública ,Sick leave ,Sick Leave ,business - Abstract
Globally, migrant and immigrant workers have borne the brunt of the COVID-19 pandemic as essential workers. They might be a Bulgarian worker at a meat processing plant in Germany, a Central American farmworker in the fields of California, or a Filipino worker at an aged-care facility in Australia. What they have in common is they are all essential workers who have worked throughout the coronavirus pandemic and have been infected with coronavirus at work. COVID-19 has highlighted the inequitable working conditions of these workers. In many instances, they are employed precariously, and so are ineligible for sick leave or social security, or COVID-19 special payments. If these are essential workers, they should get at least the same health and safety benefits of all nonessential workers. Improving the working and living conditions of migrant workers can and should be a positive outcome of the coronavirus pandemic.
- Published
- 2020
- Full Text
- View/download PDF
25. Critical Review of Diesel Exhaust Exposure Health Impact Research Relevant to Occupational Settings: Are We Controlling the Wrong Pollutants?
- Author
-
Katherine R. Landwehr, Alexander N. Larcombe, Benjamin J. Mullins, and Alison Reid
- Subjects
Pollutant ,Diesel exhaust ,Diesel particulate filter ,Health, Toxicology and Mutagenesis ,Health impact ,Public Health, Environmental and Occupational Health ,Healthy subjects ,Research findings ,complex mixtures ,Pollution ,Diesel fuel ,Environmental health ,Environmental science ,human activities ,Water Science and Technology ,International agency - Abstract
Diesel exhaust emissions and exposure of workers in occupational settings are topics which have attracted increased attention after IARC classification as a group 1 carcinogen (IARC. Agents classified by the IARC monographs, Vols. 1–120. International Agency for the Research on Cancer. http://monographs.iarc.fr/ENG/Classification/ . Accessed 21 Feb 2018; 2018). There is ongoing debate over appropriate exposure limits for occupationally exposed workers. This review consolidates recent research findings relevant to setting appropriate exposure limits, with a specific focus on newer engine and after-treatment technologies. Appropriate online databases were searched for studies published since 2005 focussing on the health effects of whole diesel exhaust exposure. Engines that used exhaust after-treatment devices including both a diesel oxidation catalyst and a diesel particulate filter were classified as new technology engines. All other studies were classified as using older technology engines. Exposure to diesel exhaust from both engine classifications resulted in negative health impacts on the lungs, heart and brain. Study participants with asthma, allergy or respiratory disease were more at risk of negative effects caused by diesel exhaust exposure than healthy subjects. Based on the published literature, an occupational limit of an average diesel exhaust concentration below 50 μg/m3 of diesel exhaust particles, 35 μg/m3 of elemental carbon, is appropriate to limit health effects. To meet this limit, many diesel engines will need to be equipped with after-treatment technology such as a DPF. However, the use of a DPF had little to no impact on measured health effects despite the removal of over 90% by weight of particles. This negates the feasibility of using particle mass-based limits.
- Published
- 2020
- Full Text
- View/download PDF
26. Asbestos-related diseases
- Author
-
Arthur W. Musk, Jennie Hui, Alison Reid, Peter Franklin, Fjh Brims, and N H de Klerk
- Subjects
Mesothelioma ,0301 basic medicine ,Pulmonary and Respiratory Medicine ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Pleural effusion ,Asbestosis ,Atelectasis ,medicine.disease_cause ,Asbestos ,03 medical and health sciences ,0302 clinical medicine ,Chrysotile ,Humans ,Medicine ,Lung cancer ,Asbestos-related diseases ,business.industry ,respiratory system ,medicine.disease ,respiratory tract diseases ,030104 developmental biology ,Infectious Diseases ,030220 oncology & carcinogenesis ,Pleura ,business - Abstract
Knowledge of asbestos-related diseases has been accumulating for over one hundred years as the industrial value of asbestos was recognised for the strength of its fibres and their resistance to destruction, resulting in increasing production and use until the multiple health effects have become apparent. Deposition in the lung parenchyma results in an inflammatory/progressively fibrotic response, with impaired gas exchange and reduced lung compliance (‘asbestosis'), causing progressive dyspnoea and respiratory failure for which only palliation is indicated, although anti-fibrotic agents used for idiopathic usual interstitial pneumonitis remain to be evaluated. Benign pleural effusion, diffuse pleural fibrosis (occasionally with associated rolled atelectasis) and pleural plaques are the non-malignant pleural diseases that result from fibres reaching the pleura. But the main issues that led to the ban on asbestos in industry are those of malignancy: lung cancer, malignant mesothelioma (MM) of the pleura and MM of the peritoneum. Bronchogenic carcinoma risk from asbestos exposure is dose-dependent and multiplies the risk attributable to tobacco smoking. The principles of treatment are as for all cases of lung cancer. Low-dose computed tomography screening of exposed people can detect early-stage, non-small cell cancers, with improved survival. The amphibole varieties of asbestos are much more potent causes of MM than chrysotile, and the risk increases exponentially for 40–50 years following first exposure. As MM is non-resectable and poorly responsive to chemotherapy and radiotherapy, curative treatment is not possible and screening not justified.
- Published
- 2020
- Full Text
- View/download PDF
27. Genomic landscape of platinum resistant and sensitive testicular cancers
- Author
-
Alex J. Cornish, Barbara Benton, Chey Loveday, Robert Huddart, James D. Brenton, Paula Proszek, Max Levy, Clare Turnbull, Peter Broderick, Charles Swanton, Richard S. Houlston, Janet Shipley, Maise Al Bakir, Kevin Litchfield, Emily Grist, Simon Chowdhury, Flavia Santo, Amy Holryod, Crispin T. Hiley, Alison Reid, Thomas Powles, Simon O'Connor, Geoff Macintyre, David Gonzalez de Castro, Darshna Dudakia, Loveday, Chey [0000-0002-2291-372X], Macintyre, Geoff [0000-0003-3906-467X], Broderick, Peter [0000-0002-8348-5829], Swanton, Charles [0000-0002-4299-3018], Huddart, Robert [0000-0003-3604-1990], Brenton, James D. [0000-0002-5738-6683], de Castro, David Gonzalez [0000-0003-0580-5636], Houlston, Richard S. [0000-0002-5268-0242], and Apollo - University of Cambridge Repository
- Subjects
Male ,0301 basic medicine ,Organoplatinum Compounds ,endocrine system diseases ,General Physics and Astronomy ,medicine.disease_cause ,0302 clinical medicine ,lcsh:Science ,Cancer genetics ,Exome sequencing ,Platinum resistant ,Mutation ,Multidisciplinary ,article ,Genomics ,Neoplasms, Germ Cell and Embryonal ,female genital diseases and pregnancy complications ,Proto-Oncogene Proteins c-kit ,030220 oncology & carcinogenesis ,Signal Transduction ,endocrine system ,DNA Copy Number Variations ,Science ,Genomic data ,Copy number analysis ,45/23 ,Biology ,General Biochemistry, Genetics and Molecular Biology ,631/67/1836 ,03 medical and health sciences ,Testicular Neoplasms ,Testicular cancer ,SDG 3 - Good Health and Well-being ,631/67/68 ,Exome Sequencing ,Platinum chemotherapy ,medicine ,Humans ,Genetic Predisposition to Disease ,Platinum ,45 ,General Chemistry ,Testicular germ cell ,030104 developmental biology ,Drug Resistance, Neoplasm ,ras Proteins ,Cancer research ,lcsh:Q ,49/61 - Abstract
While most testicular germ cell tumours (TGCTs) exhibit exquisite sensitivity to platinum chemotherapy, ~10% are platinum resistant. To gain insight into the underlying mechanisms, we undertake whole exome sequencing and copy number analysis in 40 tumours from 26 cases with platinum-resistant TGCT, and combine this with published genomic data on an additional 624 TGCTs. We integrate analyses for driver mutations, mutational burden, global, arm-level and focal copy number (CN) events, and SNV and CN signatures. Albeit preliminary and observational in nature, these analyses provide support for a possible mechanistic link between early driver mutations in RAS and KIT and the widespread copy number events by which TGCT is characterised., Most testicular germ-cell tumours are exquisitely sensitive to platinum-based chemotherapies, but little is known about why 10% are resistant. Here, the authors explore the potential underlying mechanisms by probing the genomic landscape of platinum-resistant disease.
- Published
- 2020
- Full Text
- View/download PDF
28. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
- Author
-
Xavier Garcia del Muro, Alexey Tryakin, Anis A. Hamid, Daniel Castellano, Philippe L. Bedard, Enrique Gonzalez-Billalabeitia, Anna Patrikidou, Tina Cheng, Giovannella Palmieri, Carsten Bokemeyer, Robert Kitson, Christian D. Fankhauser, Christoph Seidel, Edmond M. Kwan, Margarida Brito, Margaret Ottaviano, Aude Flechon, Thomas Hermanns, Daniel Y.C. Heng, Eitan Amir, Jose Manuel Ruiz-Morales, Alison Reid, Alexey Rumyantsev, Ben Tran, University of Zurich, and Tran, Ben
- Subjects
0301 basic medicine ,Male ,Cancer Research ,pulmonary embolism ,medicine.medical_treatment ,Gastroenterology ,0302 clinical medicine ,Catheters, Indwelling ,Risk Factors ,Antineoplastic Combined Chemotherapy Protocols ,1306 Cancer Research ,Child ,Original Research ,education.field_of_study ,Middle Aged ,Neoplasms, Germ Cell and Embryonal ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Pulmonary embolism ,testicular cancer ,Oncology ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,2730 Oncology ,Vascular Access Devices ,Adult ,medicine.medical_specialty ,Adolescent ,Retroperitoneal Lymph Node ,Population ,venous thromboembolism ,610 Medicine & health ,Risk Assessment ,lcsh:RC254-282 ,deep vein thrombosis ,03 medical and health sciences ,Young Adult ,vascular access device ,Internal medicine ,medicine ,2741 Radiology, Nuclear Medicine and Imaging ,Humans ,Radiology, Nuclear Medicine and imaging ,Retroperitoneal Neoplasms ,Retroperitoneal Space ,cardiovascular diseases ,education ,Testicular cancer ,Aged ,Retrospective Studies ,Chemotherapy ,business.industry ,Clinical Cancer Research ,germ cell tumor ,medicine.disease ,10062 Urological Clinic ,030104 developmental biology ,Germ cell tumors ,Metastatic Germ Cell Tumor ,Lymph Nodes ,Cisplatin ,business ,Venous thromboembolism - Abstract
Background Metastatic germ cell tumor (mGCT) patients receiving chemotherapy have increased risk of life‐threatening venous thromboembolism (VTE). Identifying VTE risk factors may guide thromboprophylaxis in this highly curable population. Methods Data were collected from mGCT patients receiving first‐line platinum‐based chemotherapy at 22 centers. Predefined variables included International Germ Cell Cancer Collaborative Group (IGCCCG) risk classification, long‐axis diameter of largest retroperitoneal lymph node (RPLN), Khorana score, and use of indwelling vascular access device (VAD). VTE occurring at baseline, during chemotherapy and within 90 days, was analyzed. Results Data from 1135 patients were collected. Median age was 31 years (range 10‐74). IGCCCG risk was 64% good, 20% intermediate, and 16% poor. VTE occurred in 150 (13%) patients. RPLN >3.5 cm demonstrated highest discriminatory accuracy for VTE (AUC 0.632, P, Venous thromboembolism can cause morbidity in germ cell tumor patients receiving chemotherapy; large retroperitoneal lymphadenopathy (RPLN) and indwelling vascular access devices (VAD) are significant VTE risk factors. VAD insertion should be avoided and thromboprophylaxis can be considered for large RPLN.
- Published
- 2020
29. Comparison of the ACASI Mode to Other Survey Modes in Sexual Behavior Surveys in Asia and Sub-Saharan Africa: Systematic Literature Review (Preprint)
- Author
-
Nang Nge Nge Phoo, Roanna Lobo, Daniel Vujcich, and Alison Reid
- Abstract
BACKGROUND Reliable data about sexual behaviors is fundamental in the prevention and control of HIV, hepatitis, and other sexually transmitted infections. Generally, sexual behaviors are regarded as a sociocultural taboo in Africa and Asia, and this results in biased sexual behavior survey data due to social desirability. Various modes of survey delivery, including audio computer-assisted self-interviews (ACASIs), have been investigated to improve data quality. OBJECTIVE This study aimed to review studies that compared the ACASI mode to other survey modes in sexual behavior surveys in Asia and sub-Saharan Africa to ascertain the impact of survey mode on responses to sexual behavior questions. METHODS A systematic literature review was conducted according to the Joanna Briggs Institute Manual for Evidence Synthesis. The review protocol was registered at PROSPERO (International Prospective Register of Systematic Reviews). Six databases were searched. RESULTS A total of 21 papers were included. The face-to-face interview (FTFI) mode was the survey mode most frequently compared to the ACASI mode. Among the most commonly reported outcome variable groups, ACASI participants were more likely to report sexual behaviors, such as “forced sex,” “multiple partners,” “transactional sex,” and “ever had sex,” as compared to FTFI participants. In addition to the survey mode effect, other factors were found to have had an impact on data quality, for example, participant characteristics, social norms, study design, and data collection setting. CONCLUSIONS Use of ACASIs for administering sexual behavior surveys among populations in Asia and sub-Saharan Africa demonstrated higher reports for some sexual behaviors than the use of FTFIs. More studies that compare the ACASI mode to other survey modes would improve our understanding of the usefulness of ACASIs in sexual behavior surveys in these regions.
- Published
- 2022
- Full Text
- View/download PDF
30. A Web-Based Audio Computer-Assisted Self-interview Application With Illustrated Pictures to Administer a Hepatitis B Survey Among a Myanmar-Born Community in Perth, Australia: Development and User Acceptance Study (Preprint)
- Author
-
Nang Nge Nge Phoo, Alison Reid, Roanna Lobo, Murray Davies, and Daniel Vujcich
- Abstract
BACKGROUND Self-administered paper or electronic surveys can create accessibility issues for people with language barriers and limited literacy, whereas face-to-face interviews can create privacy issues and give rise to reporting biases, particularly in the context of sensitive subject matters. An audio computer-assisted self-interview (ACASI) offers an alternative mode of survey administration, and its use has been tested against other survey modes to determine whether the presence of a background narration helps overcome literacy and privacy issues. There are still gaps with the ACASI survey administration because audio narration alone does not assist respondents with limited literacy in choosing response options. To overcome literacy issues, a few studies have used illustrated pictures for a limited number of response options. OBJECTIVE This study aimed to illustrate all the questions and response options in an ACASI application. This research is part of a larger study comparing different modes of survey administration (ACASI, face-to-face interviews, and self-administered paper surveys) to collect data on hepatitis B knowledge, attitudes, and practices among the Myanmar-born community in Perth, Australia. This study describes the 2-phase process of developing a web-based ACASI application using illustrated pictures. METHODS The first phase was the preparation of the ACASI elements, such as questionnaire, pictures, brief descriptions of response options, and audio files. Each element was pretested on 20 participants from the target population. The second phase involved synchronizing all the elements into the web-based ACASI application and adapting the application features, in particular, autoplay audio and illustrated pictures. The preprototype survey application was tested for user acceptance on 5 participants from the target population, resulting in minor adjustments to the display and arrangement of response options. RESULTS After a 12-month development process, the prototype ACASI application with illustrated pictures was fully functional for electronic survey administration and secure data storage and export. CONCLUSIONS Pretesting each element separately was a useful approach because it saved time to reprogram the application at a later stage. Future studies should also consider the participatory development of pictures and visual design of user interfaces. This picture-assisted ACASI survey administration mode can be further developed and used to collect sensitive information from populations that are usually marginalized because of literacy and language barriers.
- Published
- 2022
- Full Text
- View/download PDF
31. Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical Practice
- Author
-
Priyanka H. Patel, Nina Tunariu, Daniel S. Levine, Johann S. de Bono, Rosalind A. Eeles, Vincent Khoo, Julia Murray, Christopher C. Parker, Angela Pathmanathan, Alison Reid, Nicholas van As, and Alison C. Tree
- Subjects
Cancer Research ,Oncology - Abstract
AimsOligoprogression is poorly defined in current literature. Little is known about the natural history and significance of oligoprogression in patients with hormone-resistant prostate cancer on abiraterone or enzalutamide treatment [termed androgen receptor-targeted therapy (ARTT)]. The aim of this study was to determine the prevalence of oligoprogression, describe the characteristics of oligoprogression in a cohort of patients from a single center, and identify the number of patients potentially treatable with stereotactic body radiotherapy (SBRT).MethodsCastration-resistant prostate cancer (CRPC) patients who radiologically progressed while on ARTT were included. Patients with oligoprogressive disease (OPD) (≤3 lesions) on any imaging were identified in a retrospective analysis of electronic patient records. Kaplan–Meier method and log-rank test were used to calculate progression-free and overall survival.ResultsA total of 102 patients with metastatic CRPC on ARTT were included. Thirty (29%) patients presented with oligoprogression (46 lesions in total); 21 (21% of total) patients had lesions suitable for SBRT. The majority of lesions were in the bone (21, 46%) or lymph nodes (15, 33%). Patients with oligoprogression while on ARTT had a significantly better prostate-specific antigen (PSA) response on commencing ARTT as compared to patients who later developed polyprogression. However, PSA doubling time immediately prior to progression did not predict OPD. Median progression-free survival to oligoprogression versus polyprogression was 16.8 vs. 11.7 months. Time to further progression after oligoprogression was 13.6 months in those treated with radiotherapy (RT) for oligoprogression vs. 5.7 months in those treated with the continuation of ARTT alone.ConclusionsIn this study, nearly a third of patients on ARTT for CRPC were found to have OPD. OPD patients had a better PSA response on ART and a longer duration on ARTT before developing OPD as compared to those developing polyprogressive disease (Poly-PD). The majority of patients (70%) with OPD had lesions suitable for SBRT treatment. Prospective randomized control trials are needed to establish if there is a survival benefit of SBRT in oligoprogressive prostate cancer and to determine predictive indicators.
- Published
- 2022
32. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
- Author
-
Lisa Pickering, Richard Stone, Ian Chau, James I. MacRae, Karla Lingard, Susana Banerjee, Barry Ward, Jessica Bazin, William Gordon, Naureen Starling, Katalin A. Wilkinson, Mary O'Brien, Anna Robinson, Joanne Droney, Sacheen Kumar, Emma Nicholson, Martin Pule, Isla Leslie, Andreas M. Schmitt, Ambrosius P. Snijders, Karolina Rzeniewicz, Emma Nye, Benjamin Shum, Mary Mangwende, Scott Shepherd, Nalinie Joharatnam-Hogan, Robyn L. Shea, Michael Howell, Anthony J. Swerdlow, Shaman Jhanji, Simon Caidan, Eleanor Carlyle, Laura Amanda Boos, Annika Fendler, Kevin W. Ng, Kate Tatham, Leila Mekkaoui, Tim Slattery, Margaret Crawford, Firza Gronthoud, Philip Hobson, Camila Gomes, Robert J. Wilkinson, Jerome Nicod, Charles Swanton, Mike Gavrielides, Kim Edmonds, Robin L. Jones, Fiona Byrne, Laura Cubitt, Alison Reid, Lucy Holt, Ana Agua-Doce, Ruth Harvey, Sarah Sarker, Spyridon Gennatas, Camille L. Gerard, Andrew Furness, Hamid Ahmod, Liam Welsh, Nicholas van As, Olivia Curtis, Nadia Yousaf, Mary Wu, Nicholas C. Turner, Christina Messiou, David Cunningham, Zayd Tippu, Georgina H. Cornish, Sonia Gandhi, Helen R. Flynn, Harshil Patel, Yasir Khan, James Larkin, Lewis Au, George Kassiotis, Samra Turajlic, Maddalena Cerrone, Clemency Stephenson, Steve Gamblin, Kate Young, Wenyi Xie, Shreerang Bhide, Robert L. Goldstone, Alicia Okines, Kevin J. Harrington, Lyra Del Rosario, and Wellcome Trust
- Subjects
Cancer Research ,IMPACT ,Antibody Response ,Alpha (ethology) ,CORONAVIRUS DISEASE 2019 ,Disease ,Adaptive Immunity ,Article ,Immune system ,SEROCONVERSION ,Medicine ,Neutralizing antibody ,Cancer ,Science & Technology ,biology ,SARS-CoV-2 ,business.industry ,MORTALITY ,COVID-19 ,medicine.disease ,Titer ,SEVERITY ,Oncology ,Immunology ,Cohort ,biology.protein ,Prospective Study ,Antibody ,business ,Neutralising Antibodies ,Vaccine ,Life Sciences & Biomedicine ,T-cell Response - Abstract
Patients with cancer have higher COVID-19 morbidity and mortality. Here we present the prospective CAPTURE study, integrating longitudinal immune profiling with clinical annotation. Of 357 patients with cancer, 118 were SARS-CoV-2 positive, 94 were symptomatic and 2 died of COVID-19. In this cohort, 83% patients had S1-reactive antibodies and 82% had neutralizing antibodies against wild type SARS-CoV-2, whereas neutralizing antibody titers against the Alpha, Beta and Delta variants were substantially reduced. S1-reactive antibody levels decreased in 13% of patients, whereas neutralizing antibody titers remained stable for up to 329 days. Patients also had detectable SARS-CoV-2-specific T cells and CD4+ responses correlating with S1-reactive antibody levels, although patients with hematological malignancies had impaired immune responses that were disease and treatment specific, but presented compensatory cellular responses, further supported by clinical recovery in all but one patient. Overall, these findings advance the understanding of the nature and duration of the immune response to SARS-CoV-2 in patients with cancer.
- Published
- 2022
- Full Text
- View/download PDF
33. Are sexual health survey items understood as intended by African and Asian migrants to Australia? Methods, results and recommendations for qualitative pretesting
- Author
-
Daniel Vujcich, Meagan Roberts, Graham Brown, Jo Durham, Zhihong Gu, Lisa Hartley, Roanna Lobo, Limin Mao, Piergiorgio Moro, Amy B Mullens, Baden Offord, Enaam Oudih, and Alison Reid
- Subjects
Transients and Migrants ,05 social sciences ,Australia ,HIV & AIDS ,General Medicine ,Health Surveys ,0506 political science ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,050602 political science & public administration ,Humans ,030212 general & internal medicine ,Public Health ,Sexual Health ,qualitative research - Abstract
IntroductionMore research and policy action are needed to improve migrant health in areas such as sexual health and blood-borne viruses (SHBBV). While Knowledge, Attitudes and Practice Surveys (KAPS) can inform planning, there are no SHBBV KAPS suitable for use across culturally and linguistically diverse contexts. This study pretests one instrument among people born in Sub-Saharan Africa, South-East and North-East Asia living in Australia.MethodsEmployees of multicultural organisations were trained to collect data over three rounds using a hybrid qualitative pretesting method. Two researchers independently coded data. Researchers made revisions to survey items after each round. Responses to feedback questions in the final survey were analysed.ResultsSixty-two participants pretested the survey. Issues were identified in all three rounds of pretesting. Of the 77 final survey respondents who responded to a survey experience question, 21% agreed and 3% strongly agreed with the statement ‘I found it hard to understand some questions/words’.ConclusionIt is essential to pretest SHBBV surveys in migrant contexts. We offer the following pretesting guidance: (1) large samples are needed in heterogeneous populations; (2) intersectionality must be considered; (3) it may be necessary to pretest English language surveys in the participants’ first language; (4) bilingual/bicultural workers must be adequately trained to collect data; (5) results need to be interpreted in the context of other factors, including ethics and research aims; and (6) pretesting should occur over multiple rounds.
- Published
- 2021
34. Abstract 11270: Including the Patient’s Perspective in the Planning of Data Collection in the Recurrent Pericarditis Registry, RESONANCE
- Author
-
Sushil A Luis, Paul Cremer, Michael A Portman, ajit raisinghani, Alexandra Malinowski, Lora Marden, Alison Reid, and Dana Martin
- Subjects
Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
Introduction: In conjunction with pericardial disease physician specialists, industry experts, and recurrent pericarditis (RP) patients the RESONANCE Registry was designed to collect retrospective and prospective, longitudinal, observational data in real-world clinical practice across the United States (US). We aimed to collect data that were complete and meaningful in terms of patient experience and health related quality of life (HRQoL). Herein, we describe a novel patient-centric research approach to obtain feedback on evaluation tools for incorporation in the RESONANCE Registry (NCT04687358). Methods: Ten adult patients with a self-reported duration of disease ranging from 8 months to 25 years participated in an advisory board during which they provided feedback through a virtual platform. Their feedback informed development of multiple registry aspects. These included selection of patient reported outcomes measures (PROMs), to be collected every three months at prospective data collection timepoints, and design of several questionnaires, including evaluation of specific RP episode characteristics. Results: Prior to finalization, registry case report forms were optimized based on feedback provided by patients. Areas of data-capture informed by patient input included selection of PROMs to be assessed and patient-centric tools used for self-assessment of disease experience and HRQoL. For example, sections of a patient questionnaire were modified to include documentation of the presenting symptom, breathlessness, fear of episodes, and patient management of each episode. Conclusions: This patient-centered research collaboration resulted in enhancements to the RESONANCE Registry that enabled capture of information meaningful to patients’ daily experiences, preferences, and expectations. Patient participation in tangible aspects of research, including registry tools and design, can increase engagement with the communities that have a vested interest in improving patient care. In addition, patient involvement can help to ensure research efforts reflect the needs of not only the healthcare community but of patients alike, with an ultimate goal of improving clinical outcomes.
- Published
- 2021
- Full Text
- View/download PDF
35. Working Hard and Pushing through: A Thematic Analysis of Humanitarian Migrants’ Experiences in the Australian Workforce
- Author
-
Patricia Cain and Alison Reid
- Subjects
Employment ,Economic growth ,Battle ,Health, Toxicology and Mutagenesis ,Refugee ,media_common.quotation_subject ,integration ,Article ,Underemployment ,Political science ,Humans ,refugee ,resilience ,media_common ,Transients and Migrants ,Refugees ,Job strain ,precarious employment ,Public Health, Environmental and Occupational Health ,Australia ,health ,psychosocial work hazards ,humanitarian migrant ,Workforce ,bullying ,Medicine ,Psychological resilience ,Thematic analysis ,Psychosocial ,discrimination - Abstract
Employment can play an important role for humanitarian migrants in their successful integration into a new country. For humanitarian migrants to Australia, there are no skill or language restrictions imposed on resettlement. Despite the benefits, humanitarian migrants often find themselves in low-status jobs and precarious working conditions. The present study examines perceptions of job quality and exposure to workforce psychosocial risk factors such as job strain, bullying, and discrimination. We conducted semi-structured in-depth interviews with 30 humanitarian migrants from South Sudan, Afghanistan, and Iraq. Thematic analysis of transcripts identified three overarching themes: Uncertainty and Insecurity, Working Hard and Pushing Through, and Positive Attitudes and Actions. Overall, our findings show that despite high levels of education and long-term residency in Australia, many of the participants struggled to find a safe and secure place in the workforce. While some spoke about their work in positive terms, their comments should not be taken as confirmation of a positive work environment. Humanitarian migrants face an uphill battle against oppressive working conditions and underemployment.
- Published
- 2021
- Full Text
- View/download PDF
36. Recent advances in testicular germ cell tumours
- Author
-
Alison Reid, Robert Huddart, and Teresa Mele
- Subjects
Oncology ,Cisplatin ,medicine.medical_specialty ,Cure rate ,Chemotherapy ,germ cell cancer ,business.industry ,medicine.medical_treatment ,Disease progression ,biomarkers ,testicular germ cell tumours ,Review Article ,Disease ,Localised disease ,genetic hallmarks ,Testicular germ cell ,Internal medicine ,Platinum resistance ,medicine ,novel treatments ,business ,medicine.drug - Abstract
Testicular germ cell tumours (TGCTs) are the most common solid tumours in young men and have an excellent overall cure rate and prognosis. In most patients, localised disease is cured by surgery alone, and a minority of patients receive short-course adjuvant chemotherapy to reduce the risk of further relapse. Also, in about 80% of patients, metastatic disease can be cured by systemic cisplatin-based chemotherapy. Unfortunately, for a proportion of patients, the disease exhibits platinum resistance and relapse occurs. Despite further lines of systemic treatment, cure can be difficult to achieve in these patients and ultimately about 20% of them will die from disease progression. Addressing the mechanisms underpinning platinum resistance is critical to improving the survival and chances of cure for these patients. This review describes the latest advances in TGCT research, focusing on the identification of novel biomarkers, genetic characteristics and exploring novel treatments.
- Published
- 2021
37. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study
- Author
-
Lisa Pickering, Nalinie Joharatnam-Hogan, Fiona Kinnaird, Andrew Furness, Mary Wu, Daqi Deng, Sina Namjou, Sarah Sarker, Aljosja Rogiers, Aida Murra, Justine Korteweg, Nicholas van As, Nicholas C. Turner, Anna Robinson, Joanne Droney, Kema Peat, Shaman Jhanji, Mike Gavrielides, Isla Leslie, Lauren Dowdie, Tara Foley, Christina Messiou, Natalie Ash, Taja Barber, Andrea Emslie-Henry, Simon Caidan, Karolina Rzeniewicz, Katalin A. Wilkinson, Ruth Harvey, Annika Fendler, Kate Tatham, Andreas M. Schmitt, Sunil Iyengar, Shreerang Bhide, Kayleigh Kelly, David L.V. Bauer, Benjamin Shum, Kim Edmonds, Gail Gardner, Scott Shepherd, Mark Ethell, Laura Amanda Boos, Liam Welsh, Robert J. Wilkinson, Lucy Holt, Alicia Okines, William Gordon, James I. MacRae, Maddalena Cerrone, Kevin J. Harrington, Mary Mangwende, Hamid Ahmod, Olivia Curtis, Emma Nicholson, Darren Murray, Susana Banerjee, Firza Gronthoud, Bhavna Oza, Naureen Starling, Wenyi Xie, Alison Reid, Karla Lingard, Ana Agua-Doce, Charles Swanton, Sacheen Kumar, Lewis Au, Michael Howell, James Larkin, Camille L. Gerard, Emma C Wall, Jessica Bazin, Ian Chau, Robin L. Jones, Fiona Byrne, Robyn L. Shea, Denise Kelly, Nadia Yousaf, Steve Gamblin, Kate Young, Sonia Gandhi, Susanna Walker, Eleanor Carlyle, Javier Pascual, David Cunningham, Samra Turajlic, Clemency Stephenson, Zayd Tippu, Gavin Kelly, Mary O'Brien, Sheima Farag, Molly O’Flaherty, George Kassiotis, Wanyuan Cui, Justin Mencel, Lyra Del Rosario, Simon Rodney, and Wellcome Trust
- Subjects
Male ,Cancer Research ,T-Lymphocytes ,Antibody Response ,Adaptive Immunity ,IMMUNOGENICITY ,Antibodies, Viral ,COVID-19 VACCINATION ,Immunogenicity, Vaccine ,Neoplasms ,Longitudinal Studies ,Prospective Studies ,Neutralizing antibody ,Prospective cohort study ,Cancer ,Aged, 80 and over ,Immunity, Cellular ,biology ,Vaccination ,Middle Aged ,Acquired immune system ,Kidney Neoplasms ,Oncology ,Female ,Antibody ,Life Sciences & Biomedicine ,Neutralising Antibodies ,T-cell Response ,Adult ,COVID-19 Vaccines ,Article ,MALIGNANCIES ,Crick COVID19 consortium ,Immunity ,VACCINES ,ChAdOx1 nCoV-19 ,medicine ,Humans ,Seroconversion ,Carcinoma, Renal Cell ,Pandemics ,BNT162 Vaccine ,Aged ,Science & Technology ,business.industry ,SARS-CoV-2 ,MORTALITY ,COVID-19 ,medicine.disease ,Antibodies, Neutralizing ,DEMOGRAPHICS ,Immunology ,biology.protein ,Prospective Study ,business ,Vaccine - Abstract
Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring (CAPTURE) (NCT03226886) is a prospective cohort study of COVID-19 immunity in patients with cancer. Here we evaluated 585 patients following administration of two doses of BNT162b2 or AZD1222 vaccines, administered 12 weeks apart. Seroconversion rates after two doses were 85% and 59% in patients with solid and hematological malignancies, respectively. A lower proportion of patients had detectable titers of neutralizing antibodies (NAbT) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) versus wild-type (WT) SARS-CoV-2. Patients with hematological malignancies were more likely to have undetectable NAbT and had lower median NAbT than those with solid cancers against both SARS-CoV-2 WT and VOC. By comparison with individuals without cancer, patients with hematological, but not solid, malignancies had reduced neutralizing antibody (NAb) responses. Seroconversion showed poor concordance with NAbT against VOC. Previous SARS-CoV-2 infection boosted the NAb response including against VOC, and anti-CD20 treatment was associated with undetectable NAbT. Vaccine-induced T cell responses were detected in 80% of patients and were comparable between vaccines or cancer types. Our results have implications for the management of patients with cancer during the ongoing COVID-19 pandemic.
- Published
- 2021
- Full Text
- View/download PDF
38. 1065Diesel exposure and bladder cancer in contemporary Western Australian miners
- Author
-
Arthur W. Musk, Alison Reid, Peter Franklin, Roel Vermeulen, Susan Peters, Nicholas de Klerk, Nita Sodhi-Berry, and Lin Fritschi
- Subjects
Oncology ,Systemic inflammatory response syndrome ,medicine.medical_specialty ,Bladder cancer ,Epidemiology ,business.industry ,Internal medicine ,medicine ,Cancer ,General Medicine ,medicine.disease ,business ,Carcinogen - Abstract
Background Diesel engine exhaust (DEE) is classified as a potential carcinogen for bladder cancer in humans by the International Agency for Research on Cancer. We aimed to compare bladder cancer incidence in Western Australian miners against the general population and determine if there was an association with DEE, measured as Elemental Carbon. Methods A whole-of-population cohort of 218,846 Western Australian miners employed during 1996-2013 was followed-up until June-2017. DEE exposure data was derived from work histories and collated with administrative State-wide cancer and death data. Standardised Incidence Ratios (SIRs) were calculated to compare rates with the general population. A nested case-control study design with matching on attained age was used. Conditional logistic regression was done to calculate Odds Ratios (ORs) for cumulative Elemental Carbon exposure (unlagged and 15-year lagged), after adjusting for smoking pack-years. Results Ninety cases (88 males) were observed and 180,377 controls selected. Miners had lower bladder cancer incidence than the general population (Observed=90; Expected=135.60; SIR:0.66, 95%CI:0.53-0.80). Within miners, DEE exposure was not found to be statistically significantly associated with bladder cancer (unlagged: OR = 0.75, 95%CI: 0.43-1.31; and 15-year lagged: OR = 0.59, 95%CI:0.25-1.40), after adjusting for smoking pack-years (unlagged and lagged OR:1.02, 95%CI:1.01-1.03). Conclusions Miners had lower risk of bladder cancer than the general population. DEE exposure was not associated with bladder cancer in this nested case-control study of contemporary Western Australian miners. Key messages Diesel engine exhaust was not found to be associated with bladder cancer in miners.
- Published
- 2021
- Full Text
- View/download PDF
39. 440Women and children’s experiences of international male migration for labour in Nepal
- Author
-
Alison Reid, Jane Heyworth, Jaya A R Dantas, Julie Saunders, and Kaila Stevens
- Subjects
Epidemiology ,Political science ,media_common.quotation_subject ,Demographic economics ,General Medicine ,Empowerment ,Financial circumstances ,media_common - Abstract
Background At least 10% of the Nepalese population is estimated to be working abroad. Typically, those abroad are young men with families from agricultural backgrounds. Research regarding the impact on the family left behind in Nepal is growing but has focused on singular issues rather than the multifaceted effects of migration. This study aimed to gain an in-depth understanding of the challenges and benefits of migration for wives and children left behind. Methods Thirty-two qualitative semi-structured interviews were undertaken in Kathmandu and Kaski districts of Nepal. Eligible participants were women who had a husband who had migrated abroad for work and a child under the age of five. Interviews were conducted in Nepali, translated and transcribed to English, then coded and analysed using inductive Thematic Analysis. Results Three overarching themes were developed: Migration as a livelihood strategy, Migration as a trade-off, and Adaptation to the situation. The financial benefits of migration included improvements in children’s education and access to food and housing. Challenges identified were women’s increased labour burden inside and outside the home, psychosocial stress, and changed child-father relationships. Change in women’s empowerment was dependent on socio-demographic factors. Conclusions Migration often resulted in the improvement of economic circumstances. However, challenges being faced by women and children largely shifted from financial to emotional. Key messages The effects of migration are mediated by contextual factors. Given the ongoing reliance on migration for work, strategies should be employed to optimise the benefits and mitigate the consequences of those who remain.
- Published
- 2021
- Full Text
- View/download PDF
40. The Wittenoom legacy
- Author
-
Arthur W. Musk, Nicholas de Klerk, Enzo Merler, Jennie Hui, Bruce K. Armstrong, Nola Olsen, Nita Sodhi-Berry, Lenore Layman, Peter Franklin, Fraser Brims, Alison Reid, Keith B. Shilkin, Helman Alfonso, and Michael Hobbs
- Subjects
Lung Neoplasms ,Epidemiology ,Population ,Asbestosis ,medicine.disease_cause ,Mining ,Asbestos ,03 medical and health sciences ,0302 clinical medicine ,Blue asbestos ,Occupational Exposure ,medicine ,Humans ,030212 general & internal medicine ,Mesothelioma ,Exposure measurement ,education ,Data Linkage ,education.field_of_study ,Mortality rate ,Asbestos, Crocidolite ,Western Australia ,General Medicine ,medicine.disease ,Occupational Diseases ,Geography ,030220 oncology & carcinogenesis ,Demography - Abstract
The Wittenoom crocidolite (blue asbestos) mine and mill ceased operating in 1966. The impact of this industry on asbestos-related disease in Western Australia has been immense. Use of the employment records of the Australian Blue Asbestos Company and records of the Wittenoom township residents has permitted two cohorts of people with virtually exclusive exposure to crocidolite to be assembled and studied. Follow-up of these two cohorts has been conducted through data linkage with available hospital, mortality and cancer records. The evolution of asbestos-related disease has been recorded and, with the establishment of exposure measurements, quantitative exposure–response relationships have been estimated. There has been an ongoing epidemic of mortality from lung cancer and malignant mesothelioma and, less so, from asbestosis. Wittenoom crocidolite was used extensively in asbestos-cement products in Western Australia. As a result, the state has recorded a higher malignant-mesothelioma mortality rate than in any other Australian state and in any defined general population in the world. Thus, the legacy of Wittenoom has extended beyond the mine and the town, and is still evident more than 50 years after the closure of the mine.
- Published
- 2019
- Full Text
- View/download PDF
41. Measurement of urinary 1-aminopyrene and 1-hydroxypyrene as biomarkers of exposure to diesel particulate matter in gold miners
- Author
-
Alison Reid, Nicholas de Klerk, Novak S.J. Elliot, Arthur W. Musk, Mengran Du, Peter Franklin, Nita Sodhi-Berry, Edwin Junaldi, and Benjamin J. Mullins
- Subjects
Male ,Environmental Engineering ,Diesel exhaust ,1-hydroxypyrene ,010504 meteorology & atmospheric sciences ,Urinary system ,Population ,Air Pollutants, Occupational ,Urine ,010501 environmental sciences ,Diesel engine ,01 natural sciences ,Mining ,Occupational Exposure ,Humans ,Environmental Chemistry ,Medicine ,Polycyclic Aromatic Hydrocarbons ,education ,Waste Management and Disposal ,Vehicle Emissions ,0105 earth and related environmental sciences ,education.field_of_study ,Pyrenes ,business.industry ,Pollution ,Environmental chemistry ,Biomarker (medicine) ,business ,Body mass index ,Biomarkers ,Environmental Monitoring - Abstract
Metabolites of polycyclic aromatic hydrocarbons measured in human samples are often used as biomarkers of exposure to diesel engine exhaust (DEE). The aim of this study was to assess the changes in urinary levels of 1-aminopyrene (1-AP) and 1-hydroxypyrene (1-OHP) and their relationship with Elemental Carbon (EC), as a component of diesel engine exhaust exposure, among a hard-rock gold-mining population. Urine samples were collected at the beginning and end of a 12-hour work shift from 100 underground and above ground gold miners. Miners were fitted with personal exposure monitoring equipment to quantify exposure to DEE, measured as Elemental Carbon (EC), across their 12-hour work shift. General linear regression assessed associations of the post-shift urinary 1-AP and 1-OHP concentrations with EC, controlling for age, gender, the pre-shift biomarker level, Body Mass Index (BMI), days on current shift, time in mining, smoking status and second-hand smoke exposure. The concentrations of 1-AP and 1-OHP increased significantly across a 12-hour mining work shift. Moreover, consistent with the sensitivity analysis, the concentration of 1-AP was significantly associated with EC after adjustments. Urinary 1-OHP, but not 1-AP was significantly associated with current smoking. Urinary 1-AP may be a more robust and specific biomarker of DEE than 1-OHP.
- Published
- 2019
- Full Text
- View/download PDF
42. Strategies for Recruiting Migrants to Participate in a Sexual Health Survey: Methods, Results, and Lessons
- Author
-
Daniel Vujcich, Graham Brown, Jo Durham, Zhihong Gu, Lisa Hartley, Roanna Lobo, Limin Mao, Piergiorgio Moro, Vivienne Pillay, Amy B. Mullens, Enaam Oudih, Meagan Roberts, Caitlin Wilshin, and Alison Reid
- Subjects
Adult ,Internet ,Advertising ,Patient Selection ,Surveys and Questionnaires ,Health, Toxicology and Mutagenesis ,Public Health, Environmental and Occupational Health ,Humans ,Female ,Middle Aged ,Sexual Health ,migrants ,ethnic groups ,surveys and questionnaires ,health surveys ,sexual health ,research design ,recruitment ,community participation ,social media ,Social Media - Abstract
In this article, we describe the approaches taken to recruit adult migrants living in Australia for a sexual health and blood-borne virus survey (paper and online) and present data detailing the outcomes of these approaches. The purpose was to offer guidance to redress the under-representation of migrants in public health research. Methods of recruitment included directly contacting people in individual/organizational networks, social media posts/advertising, promotion on websites, and face-to-face recruitment at public events/venues. Search query strings were used to provide information about an online referral source, and project officers kept records of activities and outcomes. Descriptive statistical analyses were used to determine respondent demographic characteristics, proportions recruited to complete the paper and online surveys, and sources of referral. Logistic regression analyses were run to predict online participation according to demographic characteristics. The total sample comprised 1454 African and Asian migrants, with 59% identifying as female. Most respondents (72%) were recruited to complete the paper version of the survey. Face-to-face invitations resulted in the highest number of completions. Facebook advertising did not recruit large numbers of respondents. Same-sex attraction and age (40–49 years) were statistically significant predictors of online completion. We encourage more researchers to build the evidence base on ways to produce research that reflects the needs and perspectives of minority populations who often bear the greatest burden of disease.
- Published
- 2022
- Full Text
- View/download PDF
43. Translating best practice into real practice: Methods, results and lessons from a project to translate an English sexual health survey into four Asian languages
- Author
-
Daniel Vujcich, Meagan Roberts, Zhihong Gu, Shih-Chi Kao, Roanna Lobo, Limin Mao, Enaam Oudih, Nang Nge Nge Phoo, Horas Wong, and Alison Reid
- Subjects
RNA viruses ,Culture ,Social Sciences ,Multilingualism ,Surveys ,Pathology and Laboratory Medicine ,Chlamydia Infection ,Geographical Locations ,0302 clinical medicine ,Medical Conditions ,Immunodeficiency Viruses ,Sociology ,Medicine and Health Sciences ,Psychology ,030212 general & internal medicine ,Chlamydia ,Language ,Multidisciplinary ,030503 health policy & services ,Infectious Diseases ,Medical Microbiology ,Research Design ,Viral Pathogens ,Practice Guidelines as Topic ,Viruses ,Medicine ,Sexual Health ,Pathogens ,0305 other medical science ,Research Article ,China ,Asia ,Science ,Sexually Transmitted Diseases ,Research and Analysis Methods ,Microbiology ,03 medical and health sciences ,Retroviruses ,Cross-Cultural Studies ,Humans ,Microbial Pathogens ,Survey Research ,Bacteria ,Lentivirus ,Organisms ,Cognitive Psychology ,Biology and Life Sciences ,HIV ,Translating ,Health Surveys ,People and Places ,Cognitive Science ,Neuroscience - Abstract
Background Migrants are underrepresented in population health surveys. Offering translated survey instruments has been shown to increase migrant representation. While ‘team translation’ represents current best practice, there are relatively few published examples describing how it has been implemented. The purpose of this paper is to document the process, results and lessons from a project to translate an English-language sexual health and blood-borne virus survey into Khmer, Karen, Vietnamese and Traditional Chinese. Methods The approach to translation was based on the TRAPD (Translation, Review, Adjudication, Pretesting, and Documentation) model. The English-language survey was sent to two accredited, independent translators. At least one bilingual person was chosen to review and compare the translations and preferred translations were selected through consensus. Agreed translations were pretested with small samples of individuals fluent in the survey language and further revisions made. Results Of the 51 survey questions, only nine resulted in identical independent translations in at least one language. Material differences between the translations related to: (1) the translation of technical terms and medical terminology (e.g. HIV); (2) variations in dialect; and (3) differences in cultural understandings of survey concepts (e.g. committed relationships). Conclusion Survey translation is time-consuming and costly and, as a result, deviations from TRAPD ‘best practice’ occurred. It is not possible to determine whether closer adherence to TRAPD ‘best practice’ would have improved the quality of the resulting translations. However, our study does demonstrate that even adaptations of the TRAPD method can identify issues that may not have been apparent had non-team-based or single-round translation approaches been adopted. Given the dearth of clear empirical evidence about the most accurate and feasible method of undertaking translations, we encourage future researchers to follow our example of making translation data publicly available to enhance transparency and enable critical appraisal.
- Published
- 2021
44. Are There Ethnic Disparities in Exposure to Workplace Hazards Among New Zealand Migrants to Australia?
- Author
-
Sonia El-Zaemey, Alison Reid, Renee N. Carey, Alison Daly, Deborah Catherine Glass, and Lin Fritschi
- Subjects
Transients and Migrants ,Native Hawaiian or Other Pacific Islander ,Public Health, Environmental and Occupational Health ,Ethnic group ,Australia ,030210 environmental & occupational health ,03 medical and health sciences ,0302 clinical medicine ,Geography ,Cross-Sectional Studies ,Environmental health ,8. Economic growth ,Ethnicity ,Humans ,030212 general & internal medicine ,10. No inequality ,Workplace ,New Zealand - Abstract
Disparities in exposure to workplace hazards exist between Māori and non-Māori workers in New Zealand, with Māori workers generally incurring poorer conditions. This study aimed to determine if these ethnic disparities are similar after migration to Australia. A national cross-sectional telephone survey asked participants what tasks they undertook in their job to assess exposure to carcinogens as well as whether they experienced ethnic discrimination, bullying, job precariousness, or job strain. A total of 389 New Zealand Caucasians and 152 Māori/Pasifika workers were recruited. After adjustment, 79% of Māori/Pasifika compared with 67% of New Zealand Caucasian workers were assessed as being exposed to at least one carcinogen at work. Māori/Pasifika workers were also more likely to report ethnic discrimination and fair or poor current health than New Zealand Caucasians. Some ethnic disparities in exposure to workplace hazards in New Zealand are apparent after migration to Australia.
- Published
- 2021
45. How Refugees Experience the Australian Workplace: A Comparative Mixed Methods Study
- Author
-
Patricia Cain, Alison Daly, and Alison Reid
- Subjects
Gerontology ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,Refugee ,Immigration ,lcsh:Medicine ,Qualitative property ,migrants ,Racism ,Occupational safety and health ,Article ,03 medical and health sciences ,0302 clinical medicine ,Humans ,030212 general & internal medicine ,10. No inequality ,Workplace ,media_common ,Transients and Migrants ,mixed-methods ,lcsh:R ,fungi ,Public Health, Environmental and Occupational Health ,Australia ,food and beverages ,16. Peace & justice ,refugees ,030210 environmental & occupational health ,Mental health ,psychosocial hazards ,Cross-Sectional Studies ,Feeling ,8. Economic growth ,Psychosocial ,workplace exposure - Abstract
There is a growing body of evidence indicating poorer working conditions for migrant workers, particularly refugees, compared with native-born workers. Our objectives were to compare exposure to workplace psychosocial stressors in working refugees with other migrant groups and Australian-born workers of Caucasian ancestry and to describe the working experience of refugees. Cross-sectional surveys collected information on the workplace stressors of job complexity, control, security, bullying, and racial discrimination from six migrant groups (n = 1062) and Caucasian Australians (n = 1051), semi-structured face-to-face interviews were used with currently employed refugees (n = 30). Content analysis examined the qualitative data. Compared to all other groups, working refugees were more likely to report experiencing racial discrimination in the workplace and to report exposure to more than three hazards. Content analysis indicated that working refugees are working below their capacity, in terms of hours and qualifications, and in jobs that were low status and lacked security. Despite challenging work conditions, participants reported adequate health and safety training and feeling a sense of pride in their work. These findings highlight the need for better support for refugees in negotiating the workplace once they find employment and the importance of employers providing an inclusive and equitable workplace.
- Published
- 2021
46. Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
- Author
-
Rebeca Lozano, David Olmos, Adam Sharp, Penelope Flohr, Pasquale Rescigno, Alison Reid, Casilda Llácer, Ylenia Cendon, Teresa Garcés, Joaquim Mateo, Maria I Pacheco, Elena Castro, Isabel M. Aragón, Shahneen Sandhu, David Lorente, Pedro P. López-Casas, Christophe Massard, Diletta Bianchini, Nuria Romero-Laorden, Paz Nombela, Johann S. de Bono, Institut Català de la Salut, [Lozano R, Aragon IM] Genitourinary Cancer Traslational Research Group, The Institute of Biomedical Research in Málaga (IBIMA), 29010 Málaga, Spain. Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain. [Lorente D] Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain. Servicio de Oncología Médica, Hospital Provincial de Castellón, 12004 Castellón de la Plana, Spain. [Romero-Laorden N] Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain. Hospital Universitario La Princesa, 28006 Madrid, Spain. [Nombela P] Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain. [Mateo J] The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, Sutton, London SM2 5PT, UK. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Cèl·lules canceroses - Proliferació ,Neoplasms::Neoplastic Processes::Neoplasm Metastasis::Neoplastic Cells, Circulating [DISEASES] ,030232 urology & nephrology ,Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] ,Castration resistant ,circulating tumor cells ,Other subheadings::Other subheadings::/drug therapy [Other subheadings] ,Article ,03 medical and health sciences ,Prostate cancer ,PSA ,0302 clinical medicine ,Circulating tumor cell ,Metàstasi ,Internal medicine ,medicine ,docetaxel ,In patient ,Prospective cohort study ,neoplasms ,RC254-282 ,Proportional hazards model ,business.industry ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,biomarkers ,medicine.disease ,Pròstata - Càncer - Tractament ,Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms::Prostatic Neoplasms, Castration-Resistant [DISEASES] ,Pooled analysis ,Docetaxel ,neoplasias::procesos neoplásicos::metástasis neoplásica::células neoplásicas circulantes [ENFERMEDADES] ,metastatic castration-resistant prostate cancer ,030220 oncology & carcinogenesis ,neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata::neoplasias prostáticas resistentes a la castración [ENFERMEDADES] ,business ,medicine.drug - Abstract
Circulating tumor cell (CTC) enumeration and changes following treatment have been demonstrated to be superior to PSA response in determining mCRPC outcome in patients receiving AR signaling inhibitors but not taxanes. We carried out a pooled analysis of two prospective studies in mCRPC patients treated with docetaxel. CTCs were measured at baseline and 3–6 weeks post treatment initiation. Cox regression models were constructed to compare 6-month radiographical progression-free survival (rPFS), CTCs and PSA changes predicting outcome. Among the subjects, 80 and 52 patients had evaluable baseline and post-treatment CTC counts, respectively. A significant association of higher baseline CTC count with worse overall survival (OS), PFS and time to PSA progression (TTPP) was observed. While CTC response at 3–6 weeks (CTC conversion (from ≥5 to <, 5 CTCs), CTC30 (≥30% decline in CTC) or CTC0 (decline to 0 CTC)) and 6-month rPFS were significantly associated with OS (all p <, 0.005), the association was not significant for PSA30 or PSA50 response. CTC and PSA response were discordant in over 50% of cases, with outcome driven by CTC response in these patients. The c-index values for OS were superior for early CTC changes compared to PSA response endpoints, and similar to 6-month rPFS. Early CTC declines were good predictors of improved outcomes in mCRPC patients treated with docetaxel in this small study, offering a superior and/or earlier estimation of docetaxel benefit in comparison to PSA or rPFS that merits further confirmation in larger studies.
- Published
- 2021
47. Regulatory Authorities and Continuing Education Around the World: Adapting to COVID-19
- Author
-
Alison Reid, Mark Staz, and Humayun J. Chaudhry
- Subjects
Medicine (General) ,continued competency ,R5-920 ,LC8-6691 ,covid-19 pandemic ,Medical regulation ,international association of medical regulatory authorities ,Special aspects of education ,Research Article - Abstract
At a time when the world continues to be gripped by one of the most significant pandemics in history, medical regulators are understanding, more than ever, the value of effective regulation on the provision of health care locally, nationally and across national borders. It has never been more important for regulators to work together, share experiences and information, and strive for regulatory best practice.
- Published
- 2021
- Full Text
- View/download PDF
48. Comparison of the ACASI Mode to Other Survey Modes in Sexual Behavior Surveys in Asia and Sub-Saharan Africa: Systematic Literature Review
- Author
-
Nang Nge Nge Phoo, Roanna Lobo, Daniel Vujcich, and Alison Reid
- Subjects
Asia ,Sexual Behavior ,Surveys and Questionnaires ,Humans ,Health Informatics ,Africa South of the Sahara ,Systematic Reviews as Topic - Abstract
Background Reliable data about sexual behaviors is fundamental in the prevention and control of HIV, hepatitis, and other sexually transmitted infections. Generally, sexual behaviors are regarded as a sociocultural taboo in Africa and Asia, and this results in biased sexual behavior survey data due to social desirability. Various modes of survey delivery, including audio computer-assisted self-interviews (ACASIs), have been investigated to improve data quality. Objective This study aimed to review studies that compared the ACASI mode to other survey modes in sexual behavior surveys in Asia and sub-Saharan Africa to ascertain the impact of survey mode on responses to sexual behavior questions. Methods A systematic literature review was conducted according to the Joanna Briggs Institute Manual for Evidence Synthesis. The review protocol was registered at PROSPERO (International Prospective Register of Systematic Reviews). Six databases were searched. Results A total of 21 papers were included. The face-to-face interview (FTFI) mode was the survey mode most frequently compared to the ACASI mode. Among the most commonly reported outcome variable groups, ACASI participants were more likely to report sexual behaviors, such as “forced sex,” “multiple partners,” “transactional sex,” and “ever had sex,” as compared to FTFI participants. In addition to the survey mode effect, other factors were found to have had an impact on data quality, for example, participant characteristics, social norms, study design, and data collection setting. Conclusions Use of ACASIs for administering sexual behavior surveys among populations in Asia and sub-Saharan Africa demonstrated higher reports for some sexual behaviors than the use of FTFIs. More studies that compare the ACASI mode to other survey modes would improve our understanding of the usefulness of ACASIs in sexual behavior surveys in these regions.
- Published
- 2022
- Full Text
- View/download PDF
49. Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study
- Author
-
Nicholas van As, Bram Snijders, Scott Thomas Colville Shepherd, Steve Gamblin, Kate Young, Adrian Hayday, James Larkin, Ben Shum, Laura Amanda Boos, Phillip Hobson, Tim Slattery, Georgina H. Cornish, Ana Agua-Doce, Olivia Curtis, Joanne Droney, Mike Gavrielides, Alison Reid, Helen R. Flynn, Katalin A. Wilkinson, Anthony J. Swerdlow, James I. MacRae, Susana Banerjee, Lewis Au, Shreerang Bhide, Michael Howell, Martin Pule, Nicholas C. Turner, Robin L. Jones, Fiona Byrne, Spyridon Gennatas, Christina Messiou, Richard Stone, Liam Welsh, Yasir Khan, Zayd Tippu, Firza Gronthoud, Camilla Gomes, Ruth Harvey, Naureen Starling, Maddalena Cerrone, Sacheen Kumar, Wenyi Xie, Barry Ward, Alicia Okines, Kevin J. Harrington, George Kassiotis, Nadia Yousaf, Annika Fendler, Kevin W. Ng, Kate Tatham, Jerome Nicod, Emma Nye, Andrew Furness, Shaman Jhanji, Simon Caidan, David Cunningham, Leila Mekkaoui, Samra Turajlic, Charles Swanton, Camille L. Gerard, Robert L. Goldstone, Ian Chau, Jennifer Rusby, Emma Nicholson, Isla Leslie, Robert J. Wilkinson, Lisa Pickering, and Sonia Ghandi
- Subjects
Oncology ,medicine.medical_specialty ,education.field_of_study ,biology ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Population ,Cancer ,Acquired immune system ,medicine.disease ,Vaccination ,Immune profiling ,Immune system ,Internal medicine ,medicine ,biology.protein ,Antibody ,business ,education - Abstract
SUMMARYThere is a pressing need to characterise the nature, extent and duration of immune response to SARS-CoV-2 in cancer patients and inform risk-reduction strategies and preserve cancer outcomes. CAPTURE is a prospective, longitudinal cohort study of cancer patients and healthcare workers (HCWs) integrating longitudinal immune profiling and clinical annotation. We evaluated 529 blood samples and 1051 oronasopharyngeal swabs from 144 cancer patients and 73 HCWs and correlated with >200 clinical variables. In patients with solid cancers and HCWs, S1-reactive and neutralising antibodies to SARS-CoV-2 were detectable five months post-infection. SARS-CoV-2-specific T-cell responses were detected, and CD4+T-cell responses correlated with S1 antibody levels. Patients with haematological malignancies had impaired but partially compensated immune responses. Overall, cancer stage, disease status, and therapies did not correlate with immune responses. These findings have implications for understanding individual risks and potential effectiveness of SARS-CoV-2 vaccination in the cancer population.
- Published
- 2020
- Full Text
- View/download PDF
50. Differences in the Prevalence of Fruit and Vegetable Consumption in Spanish Workers
- Author
-
Julia Campos-Mora, Elena Ronda-Pérez, Alison Reid, Alba de Juan, Teresa Gea, Pablo Caballero, Universidad de Alicante. Departamento de Enfermería Comunitaria, Medicina Preventiva y Salud Pública e Historia de la Ciencia, Salud Pública, and Grupo Balmis de Investigación en Salud Comunitaria e Historia de la Ciencia
- Subjects
Male ,Future studies ,Demographic characteristics ,demographic characteristics ,Logistic regression ,0302 clinical medicine ,health behavior ,Vegetables ,Health care ,Prevalence ,occupation ,Medicine ,030212 general & internal medicine ,Occupation ,education ,Nutrition and Dietetics ,Food frequency questionnaire ,Middle Aged ,Fruit and vegetable consumption ,Medicina Preventiva y Salud Pública ,Enfermería ,Female ,0305 other medical science ,lcsh:Nutrition. Foods and food supply ,Adult ,Adolescent ,lcsh:TX341-641 ,Diet Surveys ,Article ,Education ,Young Adult ,03 medical and health sciences ,Workplace health promotion ,Environmental health ,Humans ,Working population ,work-related factors ,Occupations ,Health behavior ,Occupational Health ,Aged ,Consumption (economics) ,030505 public health ,business.industry ,Feeding Behavior ,Odds ratio ,Health Surveys ,Diet ,Cross-Sectional Studies ,Logistic Models ,Socioeconomic Factors ,Spain ,Work-related factors ,Fruit ,fruit and vegetable consumption ,business ,Food Science - Abstract
The present study aims to examine the differences in daily fruit and vegetable consumption in the working population in Spain. A cross-sectional study was conducted, using data from the 2017 National Health Survey (n = 10,700 workers aged between 18 and 65 years). The daily consumption of fruit and vegetables was evaluated using two items included in a food frequency questionnaire. Occupations were classified into the 17 main groups of the National Classification of Occupations of 2011 (CNO-11). The prevalence (P) of daily fruit and vegetable consumption was calculated in relation to sociodemographic characteristics, health behaviors, work-related characteristics and occupations. Logistic regression analysis was performed to examine the association, with simple and adjusted Odds Ratio (aOR). The P of daily consumption of fruit and vegetables in workers was 60% for fruit and 40% for vegetables. After adjusting for sociodemographic characteristics and health behaviors, workers working night or rotating shifts had a lower consumption of fruits (aOR:0.9, p <, 0.05), and those working on temporary contracts had a lower consumption of vegetables (aOR:0.8, 0.05). Engineers, scientists, health care workers and teachers had the highest fruit consumption (74.5%) and the highest vegetable consumption (55.1%). The lowest consumption of fruits was presented by the military (42.3%) and unskilled workers in the service sector (45.8%), and the lowest consumption of vegetables was presented by skilled construction workers (25.5%). These findings could aid in workplace health promotion and could be used in future studies to evaluate the impact of the activities adopted.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.